Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical need diseases, today announced the first ...

The total market size of eosinophilic esophagitis in 2023 was approximately USD 1.80 trillion in the 7MM, which is expected to grow during the forecast period (2020-2034). Among EU4 and the UK, ...

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) traded up 4.1% during mid-day trading on Tuesday . The company traded as high as $24.87 and last traded at $24.87. 67,350 shares traded hands during ...

A University of Denver virologist and biophysicist is one step closer to understanding how HIV spreads once it enters the ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

based on the Exchange Ratio, the Potential Combination would have the effect (on the basis of the assumptions set out below ...

The boards of directors (each a "Board") of HOOKIPA Pharma Inc. ("HOOKIPA") and Poolbeg Pharma plc ("Poolbeg") are pleased to announce that they have entered into non-binding discussions for an ...

Integrating AI with flow cytometry revolutionizes drug discovery and oncology, offering precise cell analysis and real-time ...